Technology Networks spoke with ACD/Labs’ Andrew Anderson about how the field of biochemical research is being changed by automation and how our new product, Katalyst D2D, hopes to speed up pharmaceutical development.
Version 2025 software on Spectrus & Percepta platforms delivers exciting updates and enhancements. Learn More.
Technology Networks spoke with ACD/Labs’ Andrew Anderson about how the field of biochemical research is being changed by automation and how our new product, Katalyst D2D, hopes to speed up pharmaceutical development.